Futures
Access hundreds of perpetual contracts
TradFi
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Introduction to Futures Trading
Learn the basics of futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to practice risk-free trading
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Pre-IPOs
Unlock full access to global stock IPOs
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
Suntory announces acquisition of Daiichi Sankyo OTC business
Mars Finance News: On April 16, it was reported that Suntory said it will acquire Daiichi Sankyo’s over-the-counter drug subsidiary, Daiichi Sankyo Healthcare. The expected acquisition amount is 246.5 billion yen. Suntory will obtain 30% of Daiichi Sankyo Healthcare’s issued shares first in June, then gradually increase its ownership stake, and plans to complete the acquisition by June 2029 to make it a wholly owned subsidiary. (Wide-angle observation)